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Abstract 
 Background: Asthma is a common and potentially serious chronic 
disease that imposes a substantial burden on patients, their families and the 
community.  
Objective: Assessment of the level of asthma control and severity in 
asthmatic children in Sulaimani city according to the global initiative for 
asthma (GINA) guidelines.  
Methods: A cross-sectional study of 82 patients who are  known cases of 
asthma, aged 5 – 15 years ,  from 1st of March 2014 to 1st of  August 2014.  
Results: Out of 82 patients in our study, 20.8%were classified as having 
intermittent asthma all of them have well controlled asthma, 42.7% of those 
classified as having mild persistent asthma 65.7% of them have well 
controlled asthma, 26.8% of those classified as having moderate persistent 
asthma 54.5% of them have partly controlled asthma, and 9.8%of those 
classified as having severe persistent asthma the majority of them 87.5% 
have uncontrolled asthma and none of them reached to the controlled asthma 
level according to GINA guidelines. Regarding the peak expiratory flow 
(PFT) we notice that 58.8% of asthmatic children who were classified as 
having intermittent severity, their PEF measurements ranged between 160-
250 l/min while those with severe persistent asthma 75% of them have 
readings between 50-150 l/min.  
Conclusion: Current levels of asthma control in the Sulaimani city fall far 
short of the goals specified in the GINA guidelines for asthma management. 
Also there is a strong correlation between PEF measurements and the level of 
asthma severity,  
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Introduction  
    Asthma is a global health problem that affects around 300 million 
individuals of all ages, ethnic groups, and countries (Bousquet et al., 2010). 
It is estimated that 250,000 people die prematurely each year as a result of 
asthma. Proper care of patients with asthma involves the triad of systematic 
chronic care plans, self-management support, and appropriate medical 
therapy (Bousquet et al., 2007).   
    The main physiological feature of asthma is episodic airway 
obstruction characterized by expiratory airflow limitation. The dominant 
pathological feature is airway inflammation, sometimes associated with 
airway structural (GINA 2012). 
       In 1993, the Global Initiative for Asthma (GINA) was formed. Its 
goals and objectives were described in a 1995 NHLBI/WHO Workshop 
Report, Global Strategy for Asthma Management and Prevention. This 
Report (revised in 2002 and 2006), and its companion documents, have been 
widely distributed and translated into many languages. A network of 
individuals and organizations interested in asthma care has been created and 
several country-specific asthma management programs have been initiated. 
Yet much work is still required to reduce morbidity and mortality from this 
chronic. The 2006 update to the Global Initiative for Asthma (GINA) 
guideline emphasizes the importance of evaluating asthma control, rather 
than asthma severity, in order to guide asthma management decisions. 
Classification of disease severity is a static measure that, whilst useful in 
initiating treatment, is less helpful in guiding subsequent treatment (GINA, 
2006; Humbert, Holgate, Boulet, & Bousquet, 2007).  
    Asthma control may be defined in a variety of ways. In lay terms, 
control may indicate disease prevention, or even cure. However, in asthma, 
where neither of these are realistic options at present, it refers to control of 
the manifestations of disease. The aim of treatment should be to achieve and 
maintain control for prolonged periods (Bateman et al., 2004). Therefore, the 
assessment of asthma control should include not only control of the clinical 
manifestations, but also control of the expected future risk to the patient such 
as exacerbations, accelerated decline in lung function, and side effects of 
treatment. In general, the achievement of good clinical control of asthma 
leads to reduce risk of exacerbations (Bateman et al., 2007).   
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  Table 1: levels of asthma (GINA 2012) 
 * Any exacerbation should prompt review of maintenance treatment to ensure that it is adequate  
† By definition, an exacerbation in any week makes that an uncontrolled asthma week ‡ Without 
administration of bronchodilator.  
   Lung function is not a reliable test for children 5 years and younger   
 
 Figure 1, describes the clinical characteristics of Controlled, Partly 
Controlled and Uncontrolled asthma. In clinical practice, this classification 
should be used in conjunction with an assessment of the patient’s clinical 
condition and the potential risks and benefits of changing treatment.  
    The previous GINA documents subdivided asthma by severity based 
on the level of symptoms, airflow limitation, and lung function variability 
into four categories (fig. 2): Intermittent, Mild Persistent, Moderate 
Persistent, or Severe Persistent, although this classification was often 
erroneously applied to patients already on treatment (Taylor et al., 2008). It 
is important to recognize, however, that asthma severity involves both the 
severity of the underlying disease and its responsiveness to treatment 
(Cockcroft & Swystun, 1996). Thus, asthma could present with severe 
symptoms and airflow obstruction, but become completely controlled with 
low-dose treatment. The main limitation of this previous method of 
classification of asthma severity was its poor value in predicting what 
treatment would be required and what a patient’s response to that treatment 
might be. For this reason, an assessment of asthma control at initial 
presentation and periodically during treatment is more relevant and useful 
(Chen et al., 2007). In view of these limitations, asthma severity is now by 
consensus classified on the basis of the intensity of treatment required to 
A. Assessment of current clinical control (preferably over 4 weeks)  
Characteristic  
Controlled (All of the 
following)  
Partly Controlled (Any 
measure present)  Uncontrolled  
Daytime symptoms  
None (twice or 
less/week)  
More than twice/week  
Three or more 
features of partly 
controlled 
asthma*†  
Limitation of activities  None  Any  
Nocturnal 
symptoms/awakening  
None  Any  
Need for reliever/ rescue 
treatment  
None (twice or 
less/week)  More than twice/week  
Lung function (PEF or  
FEV1)‡  
Normal  
<80% predicted or 
personal best (if known)  
B. Assessment of Future Risk (risk of exacerbations, instability, rapid decline in lung function, side-
effects)  
Features that are associated with increased risk of adverse events in the future include: Poor clinical 
control, frequent exacerbations in past year*, ever admission to critical care for asthma, low FEV1, 
exposure to cigarette smoke, high dose medications  
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achieve good asthma control (Cockcroft & Swystun, 1996; Taylor et al., 
2008). Mild asthma is asthma that can be well-controlled with low intensity 
treatment such as low-dose inhaled glucocorticosteroids, leukotriene 
modifiers or cromones. Severe asthma is asthma that requires high intensity 
treatment, e.g. GINA Step 4, to maintain good control, or where good control 
is not achieved despite high intensity treatment ("Proceedings of the ATS 
Workshop on Refractory Asthma," 2000). 
 Table 2: Classification of Asthma Severity (Khadadah et al., 2009) 
  
Classification 
Symptoms/Day  Symptoms/Night  
             PEF or FEV1 
 
PEF variability  
 STEP 1  
Intermittent  
< 1 time a week   
Asymptomatic and  
normal PEF between 
attacks  
≤ 2 times a month  
 >80%  
<20% 
 STEP 2  
Mild Persistent  
> 1 time a week but < 
1 time a day   
Attacks may affect 
activity  
> 2 times a month  >80%  
20-30%  
STEP 3  
Moderate  
Persistent  
Daily   
Attacks affect activity  
> 1 time a week  
 60%-80%  
------------  
> 30%  
STEP 4  
Severe Persistent  
Continuous   
Limited physical 
activity  
Frequent  
 <60%  
>30% 
 
Aim of the study 
    The aim of this study is to assess the level of asthma severity among 
patients on treatment in Sulaimani city and their level of control according to 
(GINA) guidelines of asthma management and prevention, and establishment 
of new recommendations in asthma management in Sulaimani city.  
  
Patients and methods 
    This is a cross-sectional study conducted on (82) patients who are a 
known cases of asthma already on treatment, aged (5 – 15) years, visiting 
Sulaimani Pediatric teaching hospital and the allergy and asthma center in 
Sulaimani city from 1st of March 2014 to 1st of August 2014.   
  Data regarding personal details, asthma symptoms and using of 
rescue medications information were collected from each patient, in addition 
the peak expiratory flow (PEF) measurements was done for each patient by 
peak flow meter.  
      The age groups of participants were divided into two group; 1st (5 – 
10) years and 2nd (11-15) years. Patients younger than 5 years old were 
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excluded from this study because they have difficulty in using peak flow 
meter. Care was taken not to double list any patient with frequent visits.  
     Global Initiative of Asthma (GINA) Guidelines were used to assess 
the level of asthma control as well as the severity of the disease. 
     The data collected were analyzed by SPSS software version 19 using 
statistical test (Chi- square test) and a P values < 0.05 were considered 
statistically significant.  
  
Results  
    Out of 82 asthmatic patients in the study, 47 cases (57.4%) were of 
the first age group (5 – 10 year old) , 11 (13.4%) of them have intermittent 
asthma, 19 (23.1%) of cases have mild asthma, another 14 (17.2%) of cases 
have moderate asthma and only 3 (3.7%) of cases have severe asthma. While 
the second group (11-15 year old) consists of 35 cases (42.6%), 6 (7.3%) of 
them have intermittent asthma, 16 (19.5%) of cases have mild asthma, 
another 8 (9.7%) of cases have moderate asthma and 5 (6.1%) of cases have 
severe asthma, (P value = 0.5) so there is no statistically significant 
relationship between asthma severity class and the age of patients. This is 
demonstrated in table 1.  
  Forty eight cases (58.5%) were males, 8 (9.8%) of them have 
intermittent asthma, 21 (25.6%) of cases have mild asthma,13 (15.9%) of 
cases have moderate asthma and 6 (7.3%) of cases have severe asthma. 
While 34 cases (41.5%) were females, 9 (11%) of them have intermittent 
asthma, 14 (17.1%) of cases have mild asthma, 9 (11%) of cases have 
moderate asthma and 2 (2.4%) of cases have severe asthma, (P value = 0.9) 
so there is no statistically significant relationship between asthma severity 
class and the sex of patients. This is demonstrated in table 1.   
    Table 1 also demonstrates the distribution of Asthma severity class in 
relation to family history of Asthma, in which 46 (56.1%) of cases have no 
family histories of asthma, 10 (12.2%) of them have intermittent asthma, 21 
(25.6%) of cases have mild asthma, another 10 (12.2%) of cases have 
moderate asthma and 5 (6.1%) of cases have severe asthma. While 36 
(43.9%) of cases were have positive family history of asthma, 7 (8.5%) of 
cases have intermittent asthma, 14 (17.1%) of cases have mild asthma, 
another 12 (14.6%) of cases have moderate asthma and only 3 (3.7%) of 
cases have severe asthma, (P value = 0.8) so there is no statistically 
significant relationship between asthma severity class and the family history 
of asthma in the patients.     
  Table 2 demonstrates the distribution of Asthma severity class in 
relation to Peak Expiratory Flow (PEF), we find that 6 (35.2%) of the 
intermittent class cases have a PEF readings between (160-200 l/min), in the 
mild persistent class 14 (40%) of them have PEF readings between (210-250 
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l/min), in the moderate persistent class 9 (40.9%) of them have PEF readings 
between (110-150 l/min), while in the severe persistent class 4 (50%) of 
them have PEF readings between (50-100 l/min), (P value = 0.000) so there 
is a statistically significant relationship between asthma severity class and 
the PEF measurements of the patients.  
    Regarding the relationship between the patients GINA severity class 
and their level of control we find that all patients with intermittent asthma 
(20.8% of our sample) have well-controlled disease. In patients with mild 
persistent asthma (42.7% of our sample) we find that 23 (65.7%) of them 
have well controlled disease, while in patients with moderate persistent  
(26.8% of the sample), 12 (54.5%) of them have partly controlled asthma, on 
the other hand in the severe persistent group (9.8% of the sample), we find 
that the majority 7 (87.5%) of theme have uncontrolled asthma and no one of 
them had reached to the controlled asthma level according to the GINA 
guidelines, (P value = 0.000) so there is a statistically significant relationship 
between asthma severity class and the level of asthma control of the patients. 
This is demonstrated in table 3.  
 Table 3. Distribution of Asthma severity according to age, sex and family history 
Variable                                                       GINA severity class 
                                     Intermittent                                    Persistent                                  Total 
                                                                    Mild                Moderate                Severe             
Age in Years 
       5-10                           11 (13.4)        19 (23.1)              14 (17.2)                3 (3.7)       47 (57.4) 
      11-15                            6  (7.3)         16 (19.5)                8  (9.7)                 5 (6.1)       35 (42.6) 
Sex 
      Male                             8 (9.8)          21 (25.6)                13 (15.9)              6 (7.3)       48 (58.5) 
     Female                           9 (11)          14 (17.1)                  9  (11)                 2 (2.4)       34 (41.5)            
Family history of Asthma 
        Positive                       7 (8.5)          14 (17.1)               12 (14.6)              3 (3.7)        36 (43.9) 
        Negative                     10 (12.2)      21 (25.6)                10 (12.2)             5 (6.1)        46 (56.1) 
 
 Table 4 The distribution of Asthma severity class in relation to Peak Expiratory Flow (PEF).  
PEF  
(l/min)  
  GINA Severity Class    
  Total  %  
Intermittent       Mild  Moderate  Severe  
50-100         1 (1.2)       2 (2.4)              0           4 (4.8)  7  8.5  
110-150         2 (2.4)     10 (12.2)         9 (10.9)           2 (2.4)  23  28  
160-200         6 (7.3)       6 (7.3)         6 (7.3)          1 (1.2)  19  23.1  
210-250         4 (4.8)     14 (17.1)         3 (3.7)              0  21  25.6  
260-300         3 (3.7)       3 (3.7)        4 (4.8)             0  10  12.2  
310-350         1 (1.2)           0            0          1 (1.2)  2  2.4  
Total       17 (20.8)      35 (42.7)       22 (26.8)          8 (9.8)  82  100  
P value = 0.000  
 
 Table 5. The distribution of Asthma severity class in relation to Asthma control level.  
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Level of  
control  
  GINA Severity Class    
Total  %  
Intermittent     Mild  Moderate  Severe  
   Controlled      17 (20.8)     23 (28)         4 (4.8)            0  44  53.7  
Partly 
controlled  
          0    12 (14.6)        12 (14.6)         1 (1.2)  25  30.5  
Uncontrolled            0         0         6 (7.3)         7 (8.5)  13  15.9  
Total      17 (20.8)     35 (42.7)       22 (26.8)         8 (9.8)  82  100  
P-value=0.000  
 
Discussion 
      From this study we find that (53.7%) of asthmatic patients in our 
sample have a well-controlled asthma and (15.9%) were uncontrolled, also 
we find that all of whom asthma severity classified as intermittent have a 
well-controlled asthma, those with moderate asthma (54.5%) of them have 
partly controlled asthma while those with severe asthma (87.5%) of them 
have uncontrolled asthma, i.e. there is statistically significant (P value 
<0.000) decrease in the level of control as the level of asthma severity 
increase. So current levels of asthma control in the Sulaimani city fall far 
short of the goals specified in guidelines for asthma management. This result 
is in accordance with a study, which was done in UAE 2010 (Hassan 
Mahboub, Santhakumar, Soriano, & Pawankar, 2010), a study which was 
done in Lebanon 2010 (Bahous & Soriano, 2010), also a study which was 
done in Spain 2012 (Olaguibel et al., 2012), and many other studies 
worldwide (Khadadah et al., 2009; Rabe, Vermeire, Soriano, & Maier, 2000; 
Yu et al., 2010), all showed that the Asthma control achievement is 
suboptimal fall far short of the goals specified in guidelines for asthma 
management.  Although poor asthma control may be due to underlying 
severe disease or resistance to therapy, it is far more frequently due to poor 
compliance, poor inhaler technique, inadequate patient education and lung 
function monitoring, under prescribing or environmental factors, such as 
allergen exposure or smoking, and also patient denial and reduced patient 
expectations for quality of life. Patients may also appear to have poor clinical 
asthma control due to incorrect diagnosis and/or significant co morbidities.  
    Regarding the peak expiratory flow and it relation to asthma severity 
we notice that (58.8%) of asthmatic children who were classified as having 
intermittent severity, their PEF measurements ranged between (160-250 
l/min) while those with severe persistent asthma (75%) of them have 
readings between (50-150 l/min), so there is statistically significant decrease 
in the PEF measurements (P value <0.05) as the level of asthma severity 
increase. This relationship was also noticed by many studies (Brand et al., 
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1997; Kamps, Roorda, & Brand, 2001; Cabral, Conceicao, Saldiva, & 
Martins, 2002; Bacharier et al., 2004) . PFT is a reliable test for evaluating 
small airway obstruction ( . Forced expiratory techniques are reliable for use 
in most children as young as 5−6 years of age (Zapletal & Chalupova, 2003). 
FEV1, FEV1/FVC and MMEF all relate well to asthma severity and are 
considered sensitive markers to predict airway obstruction ( Fuhlbrigge et al., 
2001; Bacharier et al., 2008). Dissociation of symptom reports with the 
degree of airflow obstruction has been noted and form part of written 
management plans, with pulmonary function monitoring to improve asthma 
control. ( Milgrom et al., 2001; Bacharier et al., 2008). 
    In our study, we did not observe a significant influence of age and 
gender on the level of asthma severity, although we observe 57.4% of our 
sample was aged between (5-10) years, and 58.5% was boys and the asthma 
severity was more severe in boys, this findings did not reach statistical 
significance (P value = 0.5 and 0.9) for the age and gender respectively. This 
result is in accordance with that of Zedan et al (2013) who found that asthma 
symptom was insignificantly related to the age and gender of asthmatic 
children, with that of Ungar et al (2011) who found that asthma were more 
predominant in boys especially those younger than 10 years old, and with 
that of Pradel et al ( 2001) who found that older children have less severe 
asthma symptom and better control than younger children, and Petsios et al 
(2013) who also found that asthma was more severe in boys than girls. In 
contrast to two other in which they found  that girls have more severe asthma 
symptom then the boys(Van De Ven, Engels, Sawyer, Otten, & Van Den 
Eijnden, 2007; Nordlund, Konradsen, Pedroletti, Kull, & Hedlin, 2011) ). 
    In addition  we did not observe a significant influence of the family 
history of asthma on the level of asthma severity in our study, this is in 
accordance with that of Roorda et al (1994) who found that no differences, 
either in symptoms or lung function were demonstrated in comparison to 
subjects with a negative family history and concluded that neither a positive 
family history, nor concurrent associated allergic diseases in the child 
contribute to the prognosis of asthma from childhood to young adulthood.  
      From this study we can conclude that, although clinical trials have 
demonstrated that asthmatic children may reach an optimal level of disease 
control, which implies minimal or absent disease impact on child life, what 
happens in real life remains far from ideal, with long-term management 
falling far short of the goals set in the GINA guidelines. This objective may 
be reached through a tailored treatment plan taking into account the 
complexity of factors that contribute to achieve and maintain this objective.  
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